Fulton Bank N.A. Has $434,000 Stake in Roche Holding AG (OTCMKTS:RHHBY)

Fulton Bank N.A. lessened its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 5.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,306 shares of the company’s stock after selling 650 shares during the period. Fulton Bank N.A.’s holdings in Roche were worth $434,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the business. Brooklyn Investment Group bought a new stake in Roche in the 3rd quarter valued at about $40,000. AlphaMark Advisors LLC bought a new stake in shares of Roche during the third quarter valued at about $149,000. IHT Wealth Management LLC purchased a new position in Roche in the 3rd quarter worth approximately $236,000. Verity Asset Management Inc. bought a new position in shares of Roche during the 3rd quarter valued at about $253,000. Finally, Canopy Partners LLC grew its holdings in shares of Roche by 4.6% in the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after purchasing an additional 344 shares during the last quarter.

Analyst Ratings Changes

Several research analysts have issued reports on RHHBY shares. Deutsche Bank Aktiengesellschaft cut shares of Roche from a “hold” rating to a “sell” rating in a report on Friday, September 13th. Bank of America upgraded Roche from a “neutral” rating to a “buy” rating in a research report on Friday, September 13th. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Roche currently has a consensus rating of “Hold”.

Roche Price Performance

Shares of RHHBY stock opened at $36.46 on Friday. The firm has a fifty day moving average of $35.96 and a two-hundred day moving average of $37.96. Roche Holding AG has a 1-year low of $29.20 and a 1-year high of $42.43.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.